Sujal M. Patel, CEO, President, and Secretary at Nautilus Biotechnology, Inc. (NAUT), bought 500,000 shares at $4.72 ($2.4M) on 2021-11-30, disclosed to the SEC on 2021-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.72 | 161,978 | $765K | 32.4% |
| 2 | $4.72 | 161,978 | $765K | 32.4% |
| 3 | $4.73 | 88,022 | $416K | 17.6% |
| 4 | $4.73 | 88,022 | $416K | 17.6% |
| Total | $4.72 avg | 500,000 | $2.4M | 100% |
| Filing → |
| NAUT | BUY | 2025-03-21 | $77K | — | Filing → |
| NAUT | BUY | 2024-03-11 | $41K | — | Filing → |
| NAUT | BUY | 2024-03-07 | $154K | — | Filing → |